Product Introduction: VENPRES-40 AMH

VENPRES-40 AMH is a premium triple-combination anti-hypertensive medication manufactured by Leeford. Composed of 40mg of Telmisartan, 5mg of Amlodipine, and 12.5mg of Hydrochlorothiazide, it is indicated for the treatment of severe essential hypertension when double combination therapy is insufficient, lowering blood pressure and reducing cardiovascular risks.

Primary Indications

• Treatment of severe essential hypertension (high blood pressure).
• Prevention of cardiovascular disease, reducing stroke and heart attack risk.
• Management of hypertension in patients with left ventricular hypertrophy.

Clinical Benefits

• Triple Action: Telmisartan relaxes blood vessels, Amlodipine dilates peripheral arteries, and Hydrochlorothiazide promotes water excretion.
• Cardioprotection: Significantly reduces cardiac preload and afterload, protecting against heart failure.
• Once-Daily Convenience: Offers reliable 24-hour blood pressure control with a single daily tablet.

Possible Side Effects

Common side effects may include:

• Dizziness, fatigue, headache, or orthostatic hypotension.
• Peripheral edema (swelling of ankles or lower legs) due to Amlodipine.
• Electrolyte imbalances, such as hypokalemia or hyponatremia.

How to Take VENPRES-40 AMH

• Take one tablet daily, with or without food, preferably in the morning.
• Swallow the tablet whole with a glass of water.
• Do not stop taking the drug abruptly, as blood pressure can rise quickly.

Mechanism of Action

VENPRES-40 AMH works through three distinct mechanisms:

• Telmisartan: Selectively blocks the angiotensin II AT1 receptor, inhibiting vasoconstriction and aldosterone release.
• Amlodipine: Inhibits calcium influx into vascular smooth muscle cells, causing peripheral vasodilation.
• Hydrochlorothiazide: Inhibits sodium and chloride reabsorption in the distal convoluted tubules, increasing water and salt excretion.

Safety Warnings

• Pregnancy & Nursing: Strictly contraindicated. Angiotensin blockers can cause fetal injury or death.
• Liver Health: Since Telmisartan is extensively cleared by bile, use with caution in hepatic impairment.
• Kidney Health: Monitor renal function regularly, especially in patients with renal artery stenosis.

Patient Advice

• Avoid standing up too quickly from a sitting or lying position to prevent dizziness.
• Monitor your blood pressure regularly and keep a record.
• Avoid potassium supplements or salt substitutes unless directed by your physician.

Fact Box

Drug Interactions

• Simvastatin: Limit simvastatin dose to 20mg daily when taking amlodipine.
• NSAIDs (Ibuprofen): May reduce the blood-pressure-lowering effect.
• Potassium-Sparing Diuretics: May cause severe hyperkalemia.

User Feedback

• Patients report highly satisfactory blood pressure control, with a significant reduction in dizziness.
• Highly recommended by clinicians as a reliable combination therapy for essential hypertension.